Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-17 4:04 pm Purchase | 2022-06-10 | 13G | Global Blood Therapeutics, Inc. GBT | Deep Track Capital LP | 3,646,690 5.600% | 3,646,690 (New Position) | Filing History |
| 2022-06-10 4:02 pm Purchase | 2022-06-01 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,436,164 5.190% | 2,436,164 (New Position) | Filing History |
| 2022-06-03 4:12 pm Purchase | 2022-05-26 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Deep Track Capital LP | 2,686,655 5.620% | 2,686,655 (New Position) | Filing History |
| 2022-05-19 4:10 pm Purchase | 2022-05-09 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Deep Track Capital LP | 917,825 5.370% | 917,825 (New Position) | Filing History |
| 2022-05-16 4:55 pm Purchase | 2022-05-06 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 3,435,200 5.410% | 985,200 (+40.21%) | Filing History |
| 2022-04-18 4:15 pm Purchase | 2022-04-14 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital LP | 3,250,000 8.110% | 3,250,000 (New Position) | Filing History |
| 2022-04-08 4:34 pm Purchase | 2022-03-31 | 13G | Agenus Inc. AGEN | Deep Track Capital LP | 775,927 5.920% | 775,927 (New Position) | Filing History |
| 2022-03-04 4:10 pm Purchase | 2022-03-02 | 13G | HOOKIPA Pharma Inc. HOOK | Deep Track Capital LP | 503,600 9.900% | 503,600 (New Position) | Filing History |
| 2022-02-18 4:11 pm Purchase | 2022-02-17 | 13G | Nkarta, Inc. NKTX | Deep Track Capital LP | 1,965,684 5.970% | 1,965,684 (New Position) | Filing History |
| 2022-02-16 4:46 pm Purchase | 2022-02-14 | 13G | Chinook Therapeutics, Inc. KDNY | Deep Track Capital LP | 2,752,070 5.040% | 2,752,070 (New Position) | Filing History |
| 2022-02-14 09:08 am Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Deep Track Capital LP | 1,900,000 4.000% | 1,334 (+0.07%) | Filing History |
| 2022-02-14 09:01 am Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 2,450,000 4.000% | -640,200 (-20.72%) | Filing History |
| 2022-02-14 09:00 am Sale | 2021-12-31 | 13G | AVROBIO, Inc. AVRO | Deep Track Capital LP | 87,511 2.410% | -96,750 (-52.51%) | Filing History |
| 2022-02-14 09:00 am Sale | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital LP | 2,100,000 5.030% | -4,600 (-0.22%) | Filing History |
| 2022-02-14 08:59 am Purchase | 2021-12-31 | 13G | Passage Bio, Inc. PASG | Deep Track Capital LP | 160,850 5.950% | 18,203 (+12.76%) | Filing History |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Deep Track Capital LP | 4,870,000 8.290% | 714,445 (+17.19%) | Filing History |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital LP | 1,300,000 5.500% | 11,276 (+0.87%) | Filing History |
| 2022-02-14 08:57 am Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital LP | 1,500,000 6.130% | 233,116 (+18.40%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital LP | 4,000,000 7.810% | 143,537 (+3.72%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital LP | 1,900,000 5.910% | 100,000 (+5.56%) | Filing History |